Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
Filed with SSE · · 6 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-using-partial-temporarily-idle-raised-funds-for-cash-management-29
Release
Suzhou Zelgen Biopharmaceuticals Co. Ltd. on 6ix
Earlier from Suzhou Zelgen Biopharmaceuticals
- Announcement on Voluntary Disclosure of Clinical Data and Latest Progress of ZG005 and ZG006 Released at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
- Announcement on Voluntary Disclosure of Phase III Clinical Trial of Recombinant Human Thyrotropin β for Injection Reaching Prespecified Primary Endpoint
- Announcement on Change of Accounting Policies
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Results of Shareholding Reduction by Shareholder, Director and Senior Management Member
Later from Suzhou Zelgen Biopharmaceuticals
- Announcement on Voluntary Disclosure of the Approval of Marketing Application for Ivarmacitinib Hydrochloride Tablets for he Treatment of Severe Alopecia Areata
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Abnormal Fluctuations in Stock Trading
- Semi-annual Report for 2026
- Announcement on Voluntary Disclosure of Acceptance of the Supplemental New Drug Application for Human Thyrotropin Beta for Injection
Follow Suzhou Zelgen Biopharmaceuticals into a list and get an email when it puts out news.
Follow Suzhou Zelgen Biopharmaceuticals